Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system

Abstract

Chromatin remodeling is one of the mechanisms by which gene expression is regulated developmentally. Chromatin structure is controlled at least in part by post-translational modification of histones, as well as by chromodomain proteins. We have identified a novel gene encoding a protein with chromatin remodeling, helicase and DNA-binding motifs. This gene, called CHD5, is the fifth member of the CHD gene family identified in humans. This gene is most homologous to CHD3 and CHD4, which encode proteins that are part of the nucleosome remodeling and histone deacetylation (NuRD) complex. CHD5 is preferentially expressed in total brain, fetal brain, and cerebellum. It is also moderately expressed in the adrenal gland, but expression is undetectable in almost all other tissues examined. CHD5 maps within a small region of deletion on 1p36.3 in human neuroblastomas, a common pediatric tumor. We examined a panel of neuroblastoma cell lines for CHD5 expression, which was consistently low or undetectable in all these lines. Expression was also examined in a panel of 137 primary neuroblastomas, and low expression was highly correlated with 1p deletion, MYCN amplification, advanced stage, and unfavorable histology. These findings suggest that this gene may play a role in the development of the nervous system, and it may also play a role in the pathogenesis of neural tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Ahringer J . (2000). Trends Genet., 16, 351–356.

  • Ayer DE, Lawrence QA and Eisenman RN (1995). Cell, 80, 767–776.

  • Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC and Kouzarides T (2001). Nature, 410, 120–124.

  • Bentley DR, Deloukas P, Dunham A, French L, Gregory SG, Humphray SJ, Mungall AJ, Ross MT, Carter NP, Dunham I, Scott CE, Ashcroft KJ, Atkinson AL, Aubin K, Beare DM, Bethel G, Brady N, Brook JC, Burford DC, Burrill WD, Burrows C, Butler AP, Carder C, Catanese JJ, Clee CM, Clegg SM, Cobley V, Coffey AJ, Cole CG, Collins JE, Conquer JS, Cooper RA, Culley KM, Dawson E, Dearden FL, Durbin RM, de Jong PJ, Dhami PD, Earthrowl ME, Edwards CA, Evans RS, Gillson CJ, Ghori J, Green L, Gwilliam R, Halls KS, Hammond S, Harper GL, Heathcott RW, Holden JL, Holloway E, Hopkins BL, Howard PJ, Howell GR, Huckle EJ, Hughes J, Hunt PJ, Hunt SE, Izmajlowicz M, Jones CA, Joseph SS, Laird G, Langford CF, Lehvaslaiho MH, Leversha MA, McCann OT, McDonald LM, McDowall J, Maslen GL, Mistry D, Moschonas NK, Neocleous V, Pearson DM, Phillips KJ, Porter KM, Prathalingam SR, Ramsey YH, Ranby SA, Rice CM, Rogers J, Rogers LJ, Sarafidou T, Scott DJ, Sharp GJ, Shaw-Smith CJ, Smink LJ, Soderlund C, Sotheran EC, Steingruber HE, Sulston JE, Taylor A, Taylor RG, Thorpe AA, Tinsley E, Warry GL, Whittaker A, Whittaker P, Williams SH, Wilmer TE, Wooster R and Wright CL . (2001).Nature, 409, 942–943.

  • Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ and Kouzarides T . (1998). Nature, 391, 597–601.

  • Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ and Kouzarides T . (1999). EMBO J., 18, 2449–2458.

  • Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD and White PS . (1997). J. Pediatr. Hematol. Oncol., 19, 93–101.

  • Delmas V, Stokes DG and Perry RP . (1993). Proc. Natl. Acad. Sci. USA, 90, 2414–2418.

  • Eggert A, Brodeur GM and Ikegaki N . (2000). Biotechniques, 28, 681–682, 686, 688–691.

  • Ge Q, Nilasena DS, O'Brien CA, Frank MB and Targoff IN . (1995). J. Clin. Invest., 96, 1730–1737.

  • Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Lazar MA, Minucci S and Pelicci PG . (1998). Nature, 391, 815–818.

  • Harper SE, Qiu Y and Sharp PA . (1996). Proc. Natl. Acad. Sci. USA, 93, 8536–8540.

  • Hogarty MD, Liu X, Guo C, Thompson PM, Weiss MJ, White PS, Sulman EP, Brodeur GM and Maris JM . (2000). Med. Pediatr. Oncol., 35, 512–515.

  • Kasten MM, Ayer DE and Stillman DJ . (1996). Mol. Cell. Biol., 16, 4215–4221.

  • Kehle J, Beuchle D, Treuheit S, Christen B, Kennison JA, Bienz M and Muller J . (1998). Science, 282, 1897–1900.

  • Kitamura K, Hoshi S, Koike M, Kiyoi H, Saito H and Naoe T . (2000). Br. J. Haematol., 108, 696–702.

  • Kozak M . (2000). Genomics., 70, 396–406.

  • Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr WH and Evans RM . (1998). Nature, 391, 811–814.

  • Luo RX, Postigo AA and Dean DC . (1998). Cell, 92, 463–473.

  • Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D and Harel-Bellan A . (1998). Nature, 391, 601–605.

  • Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC and Brodeur GM . (2001). Med. Pediatr. Oncol., 36, 32–36.

  • Maris JM, Jensen SJ, Sulman EP, Beltinger CP, Gates K, Allen C, Biegel JA, Brodeur GM and White PS . (1996). Genomics, 35, 289–298.

  • Muller J . (1995). EMBO J., 14, 1209–1220.

  • Reese MG, Hartzell G, Harris NL, Ohler U, Abril JF and Lewis SE . (2000). Genome Res., 10, 483–501.

  • Schmidt DR and Schreiber SL . (1999). Biochemistry, 38, 14711–14717.

  • Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI and DePinho RA . (1995). Cell, 80, 777–786.

  • Schreiber-Agus N and DePinho RA . (1998). BioEssays., 20, 808–818.

  • Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M and Genth E . (1995). Arthritis and Rheumatol., 38, 1389–1399.

  • Slavotinek A, Shaffer LG and Shapira SK . (1999). J. Med. Genet., 36, 657–663.

  • Struhl K . (1998). Genes Dev., 12, 599–606.

  • Sudarsanam P and Winston F . (2000). Trends Genet., 16, 345–351.

  • Tatusova TA and Madden TL . (1999). FEMS Microbiol. Lett., 174, 247–250.

  • Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM and White PS . (2001). Cancer Res., 61, 679–686.

  • Tong JK, Hassig CA, Schnitzler GR, Kingston RE and Schreiber SL . (1998). Nature, 395, 917–921.

  • White PS, Maris JM, Sulman EP, Jensen SJ, Kyemba SM, Beltinger CP, Allen C, Kramer DL, Biegel JA and Brodeur GM . (1997). Eur. J. Cancer, 33, 1957–1961.

  • White PS, Thompson PM, Seifried BA, Sulman EP, Jensen SJ, Guo C, Maris JM, Hogarty MD, Allen C, Matise TC, Gregory SG, Reynolds CP and Brodeur GM . (2001). Med. Pediatr. Oncol., 36, 37–41.

  • Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, Ghaffari S, Iliev D, Penn B, Woodland AM, Smith R, Salada G, Carillo A, Laity K, Gupte J, Swedlund B, Tavtigian SV, Teng DH and Lees (2000). Cancer Res., 60, 6171–6177.

  • Woodage T, Basrai MA, Baxevanis AD, Hieter P and Collins FS . (1997). Proc. Natl. Acad. Sci. USA, 94, 11472–11477.

  • Wu YQ, Heilstedt HA, Bedell JA, May KM, Starkey DE, McPherson JD, Shapira SK and Shaffer LG . (1999). Human Mol. Genet., 8, 313–321.

  • Xue Y, Wong J, Moreno GT, Young MK, Cote J and Wang W . (1998). Mol Cell, 2, 851–861.

  • Yarden RI and Brody LC . (1999). Proc. Natl. Acad. Sci. USA, 96, 4983–4988.

  • Zhang Y, LeRoy G, Seelig HP, Lane WS and Reinberg D . (1998). Cell, 95, 279–289.

Download references

Acknowledgements

This work was supported in part by National Institutes of Health Grant CA-39771, the Otto Haas Charitable Trust #2, and the Audrey E Evans Endowed Chair (GMB).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Garrett M Brodeur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thompson, P., Gotoh, T., Kok, M. et al. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene 22, 1002–1011 (2003). https://doi.org/10.1038/sj.onc.1206211

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206211

Keywords

This article is cited by

Search

Quick links